# Efficacy and Tolerability of Intranasal Fentanyl Spray for the Treatment of Breakthrough Pain in Cancer Patients Older Than 18 Years

> **NCT00994760** · — · COMPLETED · sponsor: **Takeda** · enrollment: 131 (actual)

## Conditions studied

- Breakthrough Pain
- Cancer

## Interventions

- **DRUG:** Instanyl (Intranasal Fentanyl)

## Key facts

- **NCT ID:** NCT00994760
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2010-09
- **Final completion:** 2010-11
- **Target enrollment:** 131 (ACTUAL)
- **Last updated:** 2012-09-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00994760

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00994760, "Efficacy and Tolerability of Intranasal Fentanyl Spray for the Treatment of Breakthrough Pain in Cancer Patients Older Than 18 Years". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00994760. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*